Compare $DYAI vs $TCRX | Chartloom

Compare

$DYAI vs $TCRX

Dyadic International Inc · TScan Therapeutics Inc

DYAI

Dyadic International Inc

TCRX

TScan Therapeutics Inc

Compare $DYAI vs $TCRX

Comparing Dyadic International Inc and TScan Therapeutics Inc

DYAIDyadic International Inc

TCRXTScan Therapeutics Inc

DYAIDyadic International Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.15x

Rev growth (TTM)

-8.1%

YTD performance

-52.8%

52W performance

-60.7%

FCF yield

-45.8%

TCRXTScan Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.85x

Rev growth (TTM)

2.2%

YTD performance

-76.7%

52W performance

-88.0%

FCF yield

-761.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DYAI

TCRX

Detailed metrics comparison

DYAI

Dyadic International Inc

TCRX

TScan Therapeutics Inc

Market Cap

DYAI$16M

TCRX$16M

Enterprise Value

DYAI$20M

TCRX$-52M

Price

DYAI$0.44

TCRX$0.24

P/E Ratio

DYAIN/A

TCRXN/A

P/S Ratio

DYAI4.26x

TCRX2.19x

EV/Sales

DYAI5.21x

TCRX-7.29x

EV/EBITDA

DYAI75.44x

TCRX0.00x

P/B Ratio

DYAI14.82x

TCRX0.31x

P/FCF Ratio

DYAIN/A

TCRXN/A

EV/FCF

DYAI-2.67x

TCRX0.44x

PEG Ratio

DYAIN/A

TCRXN/A

Forward P/E (NTM)

DYAIN/A

TCRXN/A

Forward P/S (NTM)

DYAI2.15x

TCRX8.85x

Revenue (TTM)

DYAI$4M

TCRX$7M

Revenue Growth (YoY)

DYAI-8.1%

TCRX2.2%

Forward Rev Growth

DYAI91.1%

TCRX42.6%

Gross Margin (TTM)

DYAI16.2%

TCRX0.0%

Operating Margin (TTM)

DYAI0.0%

TCRX0.0%

EBITDA Margin (TTM)

DYAI-194.5%

TCRX-1626.5%

Net Margin (TTM)

DYAI-200.5%

TCRX-1655.4%

FCF Margin (TTM)

DYAI-194.7%

TCRX-1665.6%

Net Income (TTM)

DYAI$-8M

TCRX$-118M

FCF (TTM)

DYAI$-7M

TCRX$-118M

EPS (TTM)

DYAI-$0.21

TCRX-$0.91

ROE (TTM)

DYAI-35086.0%

TCRX-10872.0%

ROA (TTM)

DYAI-8477.0%

TCRX-5447.0%

ROIC (TTM)

DYAI-8444.0%

TCRX-8356.0%

Cash

DYAI$1M

TCRX$100M

Debt

DYAI$5M

TCRX$33M

Net Cash/Debt

DYAI$-4M

TCRX$67M

Current Ratio (TTM)

DYAI1.65x

TCRX3.37x

Quick Ratio (TTM)

DYAI1.54x

TCRX3.23x

Debt/Equity (TTM)

DYAI4.08x

TCRX0.47x

Debt/Assets (TTM)

DYAI0.0%

TCRX0.0%

Interest Coverage (TTM)

DYAIN/A

TCRXN/A

Net Debt/EBITDA (TTM)

DYAI0.00x

TCRX0.00x

Beta

DYAI1.09

TCRX1.19

52W Performance

DYAI-60.7%

TCRX-88.0%

YTD Performance

DYAI-52.8%

TCRX-76.7%

% from 52W High

DYAI-72.2%

TCRX-90.7%

% from 52W Low

DYAI30.6%

TCRX6.1%

Asset Turnover (TTM)

DYAI0.42x

TCRX0.03x

FCF Yield (TTM)

DYAI-45.8%

TCRX-761.5%

Earnings Yield (TTM)

DYAI-47.1%

TCRX-756.8%

Dividend Yield (TTM)

DYAIN/A

TCRXN/A

Rule of 40

DYAI-202.8

TCRX-1,663.4

EV/GP/RG

DYAI0.30

TCRXN/A

Ticker research

View DYAI research View TCRX research

Metric	DYAI Dyadic International Inc	TCRX TScan Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$20M	$-52M
Price	$0.44	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	4.26x	2.19x
EV/Sales	5.21x	-7.29x
EV/EBITDA	75.44x	0.00x
P/B Ratio	14.82x	0.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.67x	0.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.15x	8.85x
Revenue & Growth
Revenue (TTM)	$4M	$7M
Revenue Growth (YoY)	-8.1%	2.2%
Forward Rev Growth	91.1%	42.6%
Profitability
Gross Margin (TTM)	16.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.5%	-1626.5%
Net Margin (TTM)	-200.5%	-1655.4%
FCF Margin (TTM)	-194.7%	-1665.6%
Net Income (TTM)	$-8M	$-118M
FCF (TTM)	$-7M	$-118M
EPS (TTM)	-$0.21	-$0.91
ROE (TTM)	-35086.0%	-10872.0%
ROA (TTM)	-8477.0%	-5447.0%
ROIC (TTM)	-8444.0%	-8356.0%
Financial Health
Cash	$1M	$100M
Debt	$5M	$33M
Net Cash/Debt	$-4M	$67M
Current Ratio (TTM)	1.65x	3.37x
Quick Ratio (TTM)	1.54x	3.23x
Debt/Equity (TTM)	4.08x	0.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.19
52W Performance	-60.7%	-88.0%
YTD Performance	-52.8%	-76.7%
% from 52W High	-72.2%	-90.7%
% from 52W Low	30.6%	6.1%
Efficiency & Yields
Asset Turnover (TTM)	0.42x	0.03x
FCF Yield (TTM)	-45.8%	-761.5%
Earnings Yield (TTM)	-47.1%	-756.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-202.8	-1,663.4
EV/GP/RG	0.30	N/A
Ticker research	View DYAI research	View TCRX research

Valuation

P/S Ratio

TCRX

2.19x

DYAI

4.26x

EV/FCF

DYAI

-2.67x

TCRX

0.44x

Growth & revenue

Revenue Growth TTM

TCRX

2.2%

DYAI

-8.1%

Forward Revenue Growth

DYAI

91.1%

TCRX

42.6%

Profitability & performance

Gross Margin

DYAI

16.2%

TCRX

0.0%

ROE

TCRX

-10872.0%

DYAI

-35086.0%

FCF Yield %

DYAI

-45.8%

TCRX

-761.5%

52-Week Performance

DYAI

-60.7%

TCRX

-88.0%

Detailed metrics comparison

DYAI

Dyadic International Inc

TCRX

TScan Therapeutics Inc

Market Cap

DYAI$16M

TCRX$16M

Enterprise Value

DYAI$20M

TCRX$-52M

Price

DYAI$0.44

TCRX$0.24

P/E Ratio

DYAIN/A

TCRXN/A

P/S Ratio

DYAI4.26x

TCRX2.19x

EV/Sales

DYAI5.21x

TCRX-7.29x

EV/EBITDA

DYAI75.44x

TCRX0.00x

P/B Ratio

DYAI14.82x

TCRX0.31x

P/FCF Ratio

DYAIN/A

TCRXN/A

EV/FCF

DYAI-2.67x

TCRX0.44x

PEG Ratio

DYAIN/A

TCRXN/A

Forward P/E (NTM)

DYAIN/A

TCRXN/A

Forward P/S (NTM)

DYAI2.15x

TCRX8.85x

Revenue (TTM)

DYAI$4M

TCRX$7M

Revenue Growth (YoY)

DYAI-8.1%

TCRX2.2%

Forward Rev Growth

DYAI91.1%

TCRX42.6%

Gross Margin (TTM)

DYAI16.2%

TCRX0.0%

Operating Margin (TTM)

DYAI0.0%

TCRX0.0%

EBITDA Margin (TTM)

DYAI-194.5%

TCRX-1626.5%

Net Margin (TTM)

DYAI-200.5%

TCRX-1655.4%

FCF Margin (TTM)

DYAI-194.7%

TCRX-1665.6%

Net Income (TTM)

DYAI$-8M

TCRX$-118M

FCF (TTM)

DYAI$-7M

TCRX$-118M

EPS (TTM)

DYAI-$0.21

TCRX-$0.91

ROE (TTM)

DYAI-35086.0%

TCRX-10872.0%

ROA (TTM)

DYAI-8477.0%

TCRX-5447.0%

ROIC (TTM)

DYAI-8444.0%

TCRX-8356.0%

Cash

DYAI$1M

TCRX$100M

Debt

DYAI$5M

TCRX$33M

Net Cash/Debt

DYAI$-4M

TCRX$67M

Current Ratio (TTM)

DYAI1.65x

TCRX3.37x

Quick Ratio (TTM)

DYAI1.54x

TCRX3.23x

Debt/Equity (TTM)

DYAI4.08x

TCRX0.47x

Debt/Assets (TTM)

DYAI0.0%

TCRX0.0%

Interest Coverage (TTM)

DYAIN/A

TCRXN/A

Net Debt/EBITDA (TTM)

DYAI0.00x

TCRX0.00x

Beta

DYAI1.09

TCRX1.19

52W Performance

DYAI-60.7%

TCRX-88.0%

YTD Performance

DYAI-52.8%

TCRX-76.7%

% from 52W High

DYAI-72.2%

TCRX-90.7%

% from 52W Low

DYAI30.6%

TCRX6.1%

Asset Turnover (TTM)

DYAI0.42x

TCRX0.03x

FCF Yield (TTM)

DYAI-45.8%

TCRX-761.5%

Earnings Yield (TTM)

DYAI-47.1%

TCRX-756.8%

Dividend Yield (TTM)

DYAIN/A

TCRXN/A

Rule of 40

DYAI-202.8

TCRX-1,663.4

EV/GP/RG

DYAI0.30

TCRXN/A

Ticker research

View DYAI research View TCRX research

Metric	DYAI Dyadic International Inc	TCRX TScan Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$20M	$-52M
Price	$0.44	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	4.26x	2.19x
EV/Sales	5.21x	-7.29x
EV/EBITDA	75.44x	0.00x
P/B Ratio	14.82x	0.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.67x	0.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.15x	8.85x
Revenue & Growth
Revenue (TTM)	$4M	$7M
Revenue Growth (YoY)	-8.1%	2.2%
Forward Rev Growth	91.1%	42.6%
Profitability
Gross Margin (TTM)	16.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.5%	-1626.5%
Net Margin (TTM)	-200.5%	-1655.4%
FCF Margin (TTM)	-194.7%	-1665.6%
Net Income (TTM)	$-8M	$-118M
FCF (TTM)	$-7M	$-118M
EPS (TTM)	-$0.21	-$0.91
ROE (TTM)	-35086.0%	-10872.0%
ROA (TTM)	-8477.0%	-5447.0%
ROIC (TTM)	-8444.0%	-8356.0%
Financial Health
Cash	$1M	$100M
Debt	$5M	$33M
Net Cash/Debt	$-4M	$67M
Current Ratio (TTM)	1.65x	3.37x
Quick Ratio (TTM)	1.54x	3.23x
Debt/Equity (TTM)	4.08x	0.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.19
52W Performance	-60.7%	-88.0%
YTD Performance	-52.8%	-76.7%
% from 52W High	-72.2%	-90.7%
% from 52W Low	30.6%	6.1%
Efficiency & Yields
Asset Turnover (TTM)	0.42x	0.03x
FCF Yield (TTM)	-45.8%	-761.5%
Earnings Yield (TTM)	-47.1%	-756.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-202.8	-1,663.4
EV/GP/RG	0.30	N/A
Ticker research	View DYAI research	View TCRX research